CIPRIANI, Andrea
 Distribuzione geografica
Continente #
NA - Nord America 6.606
EU - Europa 6.072
AS - Asia 3.026
SA - Sud America 362
AF - Africa 23
OC - Oceania 18
Continente sconosciuto - Info sul continente non disponibili 11
Totale 16.118
Nazione #
US - Stati Uniti d'America 6.562
GB - Regno Unito 2.285
SG - Singapore 1.417
CN - Cina 1.316
IT - Italia 807
FR - Francia 569
RU - Federazione Russa 539
FI - Finlandia 451
DE - Germania 400
IE - Irlanda 385
SE - Svezia 331
BR - Brasile 327
UA - Ucraina 153
VN - Vietnam 73
HK - Hong Kong 50
TR - Turchia 43
NL - Olanda 40
JP - Giappone 29
CA - Canada 27
AT - Austria 19
IL - Israele 19
AU - Australia 18
RO - Romania 17
BE - Belgio 16
ID - Indonesia 12
MX - Messico 11
AR - Argentina 9
CH - Svizzera 9
ES - Italia 9
EU - Europa 9
IN - India 7
UY - Uruguay 7
PK - Pakistan 6
PL - Polonia 6
ZA - Sudafrica 6
AZ - Azerbaigian 5
BD - Bangladesh 5
BG - Bulgaria 5
GR - Grecia 5
HU - Ungheria 5
PY - Paraguay 5
EC - Ecuador 4
EG - Egitto 4
IQ - Iraq 4
IR - Iran 4
KE - Kenya 4
KR - Corea 4
MA - Marocco 4
PH - Filippine 4
SK - Slovacchia (Repubblica Slovacca) 4
BY - Bielorussia 3
LB - Libano 3
PE - Perù 3
SA - Arabia Saudita 3
UZ - Uzbekistan 3
VE - Venezuela 3
AM - Armenia 2
CL - Cile 2
CZ - Repubblica Ceca 2
JO - Giordania 2
KH - Cambogia 2
KZ - Kazakistan 2
LT - Lituania 2
NG - Nigeria 2
RS - Serbia 2
SC - Seychelles 2
SI - Slovenia 2
A2 - ???statistics.table.value.countryCode.A2??? 1
AE - Emirati Arabi Uniti 1
AL - Albania 1
BN - Brunei Darussalam 1
BO - Bolivia 1
CO - Colombia 1
CR - Costa Rica 1
DK - Danimarca 1
DO - Repubblica Dominicana 1
DZ - Algeria 1
EE - Estonia 1
GE - Georgia 1
GT - Guatemala 1
HN - Honduras 1
JM - Giamaica 1
KG - Kirghizistan 1
LU - Lussemburgo 1
LV - Lettonia 1
MN - Mongolia 1
MO - Macao, regione amministrativa speciale della Cina 1
NP - Nepal 1
PA - Panama 1
PS - Palestinian Territory 1
PT - Portogallo 1
TH - Thailandia 1
TJ - Tagikistan 1
TW - Taiwan 1
XK - ???statistics.table.value.countryCode.XK??? 1
Totale 16.118
Città #
Southend 2.103
Jacksonville 1.297
Woodbridge 967
Singapore 861
Chandler 841
Ann Arbor 580
Houston 549
Dublin 385
Wilmington 222
Lawrence 216
Princeton 216
Beijing 209
Ashburn 186
Verona 153
Nanjing 128
Jinan 110
New York 107
Shenyang 103
Milan 95
The Dalles 92
Hebei 73
Dong Ket 56
Helsinki 51
Hong Kong 50
Sindelfingen 47
Changsha 45
Nanchang 45
Tianjin 45
Rome 43
Haikou 40
Ningbo 35
Hangzhou 34
Boardman 33
Washington 32
Norwalk 31
Dearborn 30
Redwood City 30
Guangzhou 29
Taiyuan 29
Zhengzhou 28
Jiaxing 25
São Paulo 25
Taizhou 24
Bologna 22
Moscow 21
Lancaster 20
San Francisco 18
Tokyo 18
Toronto 18
Santa Clara 16
Florence 15
Fuzhou 15
Los Angeles 15
Brussels 14
Düsseldorf 13
Falls Church 13
Lanzhou 12
London 12
Nuremberg 11
Shanghai 11
Belo Horizonte 10
Brasília 10
Campinas 10
Jakarta 10
Munich 10
Council Bluffs 9
Fairfield 9
Mexico City 9
Naples 9
Seattle 9
Amsterdam 8
Cagliari 8
Rio de Janeiro 8
Timisoara 8
Vienna 8
Dongguan 7
Groningen 7
Kent 7
Berlin 6
Canberra 6
Guarulhos 6
Isorella 6
Joinville 6
Melbourne 6
Montevideo 6
Zurich 6
Auburn Hills 5
Baku 5
Catania 5
Dallas 5
Genoa 5
Stockholm 5
Trento 5
Athens 4
Brampton 4
Bratislava 4
Brescia 4
Contagem 4
Curitiba 4
Frankfurt am Main 4
Totale 10.831
Nome #
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 458
Efficacia del litio nella depressione resistente con rischio suicidario. Studio indipendente, pragmatico, multicentrico, di superiorità 324
[(123)I]FP-CIT single photon emission computed tomography findings in drug-induced Parkinsonism. 176
Development of a registry for monitoring psychotropic drug prescriptions: Aims, methods and implications for ordinary practice and research 142
[Randomized trials, systematic reviews, meta-analyses: basic criteria in the world of scientific evidence]. 134
Assessing risk of bias in randomized controlled trials 131
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia in routine clinical care: a randomized, controlled trial 128
Trazodone nell'anziano con problemi di insonnia: quale il razionale? 126
Commentary: Haloperidol, risperidone and olanzapine are similarly effective for first-episode non-affective psychosis but have differing side effects 125
What is a run-in phase? 124
What is a systematic review? 119
Are all antidepressants really the same? The case of fluoxetine: a systematic review 115
Antidepressants and benzodiazepines for panic disorder in adults 114
Associazione tra TCA e SSRI nella depressione resistente 112
Imputing missing standard deviations in meta-analyses can provide accurate results 110
Efficacy of pharmacotherapy against core traits of borderline personality disorder: Meta-analysis of randomized controlled trials 107
What is a forest plot? 106
Allocation concealment and blinding in clinical trials 105
Citalopram versus other anti-depressive agents for depression 105
An approach for modelling multiple correlated outcomes in a network of interventions using odds ratios 105
Agomelatine and the brave old world of narrative-based medicine 104
Randomized trials published in Chinese or Western journals: comparative empirical analysis 104
Antidepressant drug prescription and risk of abnormal bleeding. A case-control study 102
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: results and lessons of an underpowered randomised clinical trial 102
Sertraline versus other antidepressive agents for depression 101
Antidepressive Monotherapie 100
Effect of antipsychotic drugs on cerebrovascular morbidity and mortality: a systematic review 100
Trasformare la pratica clinica in ricerca. Un invito a partecipare allo studio CHAT 100
What is a risk ratio? 100
Persistence with pharmacological treatment in the specialist mental healthcare of patients with severe mental disorders 100
Efficacy of selective serotonin reuptake inhibitors and adverse events: meta-regression and mediation analysis of placebo-controlled trials 100
Adding aripiprazole improves major depressive disorder following incomplete response to antidepressants alone 98
Aripiprazole versus haloperidol in combination with clozapine for treatment-resistant schizophrenia: a 12-month, randomized, naturalistic trial 97
Rationale and design of an independent randomised controlled trial evaluating the effectiveness of aripiprazole or haloperidol in combination with clozapine for treatment-resistant schizophrenia 97
Seven criteria for improving effectiveness trials in psychiatry 96
Evidence-based guidelines for treating bipolar disorder: Revised third edition recommendations from the British Association for Psychopharmacology 96
Depressive disorders 95
Conventional vs. atypical antipsychotic medications [Letter] 95
Understanding antipsychotic non-classical prescriptions: a quantitative and qualitative approach 95
Beneficial and adverse effects of antidepressants on suicide mortality in individuals with major depression 94
Antipsychotic drugs and cerebrovascular events in elderly patients with dementia: a systematic review 93
Comparative efficacy and tolerability of 15 antipsychotic drugs in schizophrenia: a multiple-treatments meta-analysis 92
Citalopram versus other anti-depressive agents for depression 91
Forensic database study suggests selective serotonin reuptake inhibitors do not increase the risk of suicide in people taking antidepressants 89
Use of antipsychotic drugs and mood stabilizers in women of childbearing age with schizophrenia and bipolar disorder: epidemiological survey. 89
Fluoxetine versus other types of pharmacotherapy for depression (Review) 88
Duloxetine versus other anti-depressive agents for depression 88
Azapirones versus placebo for panic disorder in adults 88
What is a clinical trial protocol? 87
Antidepressants and suicide symptoms: compelling new insights from the FDA's analysis of individual patient level data 86
Adherence therapy does not improve quality of life in people with schizophrenia [Comment] 86
Comparative efficacy and tolerability of pharmacological interventions for attention-deficit/hyperactivity disorder in children, adolescents and adults: protocol for a systematic review and network meta-analysis 86
Implementation of treatment guidelines for specialist mental health care 86
Dalle revisioni narrative a quelle sitematiche e alle metanalisi, per un approccio moderno alla valutazione dei trattamenti farmacologici in psichiatria 85
Selective serotonin reuptake inhibitors and risk of suicide: A systematic review of observational studies 85
Effectiveness of lithium in subjects with treatment-resistant depression and suicide risk: a protocol for a randomised, independent, pragmatic, multicentre, parallel-group, superiority clinical trial 85
"Wish bias" in antidepressant drug trials? 84
Comparative efficacy and acceptability of antimanic drugsin acute mania: a multiple-treatments meta-analysis 84
Citalopram versus other anti-depressive agents for depression. 84
Paroxetine versus other anti-depressive agents for depression 84
Mirtazapine versus other antidepressive agents for depression 84
Commentary on: Analysis and reporting of factorial trials: a systematic review (McAlister et al., JAMA) 83
Comparison of systematic and narrative reviews: the example of the atypical antipsychotics 83
Fluoxetine versus other types of pharmacotherapy for depression (Protocol for a Cochrane Review) 82
Benzodiazepines and risk of dementia: true association or reverse causation? 82
Implementation of treatment guidelines for specialist mental health care 81
Comparative efficacy and tolerability of medications for attention-deficit hyperactivity disorder in children, adolescents, and adults: a systematic review and network meta-analysis 81
Suicide, depression, and antidepressants. Patients and clinicians need to balance benefits and harms 80
Impact of regulatory changes on first- and second-generation antipsychotic drug consumption and expenditure in Italy 80
Outcome reporting bias in clinical trials 80
Do selective serotonin reuptake inhibitors cause suicide? Authors' reply to Raven 78
Risk of suicidal behaviour in adults taking antidepressants 78
Trasformare la pratica clinica in ricerca. Un invito a partecipareallo studio CHAT. 78
What is a factorial trial? 78
What is a multiple treatments meta-analysis? 78
Benzodiazepine use in the real world of psychiatric practice: low-dose, long-term drug taking and low rates of treatment discontinuation 77
Antidepressants for Bipolar Disorder 77
Understanding and using systematic literature reviews 77
Inglobare la ricerca nella pratica clinica quotidiana 76
Validity of the impact factor of journals as a measure of randomised controlled trial quality 76
Why internal and external validity of experimental studies are relevant for clinical practice? 76
What is an intention to treat analysis? 76
Review: Short-term benefit of escitalopram versus citalopram for depression uncertain, but big difference in French health insurance costs. 76
Comparative efficacy and acceptability of 12 new-generation antidepressants: a multiple-treatments meta-analysis 76
Haloperidol alone or in combination for acute mania 75
Levels of evidence: can quality of systematic reviews be quantified? 75
Implementation of treatment guidelines for specialist mental health care 75
Conceptual and technical challenges in network meta-analysis 75
Lithium in the prevention of suicidal behavior and all-cause mortality in patients with mood disorders: A systematic review of randomized trials 74
Imputing response rates from means and standard deviations in meta-analyses 74
What is an individual patient data meta-analysis? 74
Pharmacological treatment for unipolar psychotic depression 73
Psychological therapies versus pharmacotherapy for obsessive compulsive disorder (Protocol) 73
Olanzapine in long-term treatment for bipolar disorder. 73
Agomelatine efficacy and acceptability revisited: systematic review and meta-analysis of published and unpublished randomised trials 73
What is a randomised controlled trial? 72
A primer on network meta-analysis with emphasis on mental health 72
Lithium in the prevention of suicide in mood disorders: updated systematic review and meta-analysis 72
Aripiprazole in addition to clozapine in partially responsive patients with schizophrenia: a critical review of case series 71
Imaging of the dopamine transporter predicts pattern of disease progression and response to levodopa in patients with schizophrenia and parkinsonism: A 2-year follow-up multicenter study. 71
Totale 9.747
Categoria #
all - tutte 58.487
article - articoli 54.688
book - libri 267
conference - conferenze 0
curatela - curatele 0
other - altro 1.661
patent - brevetti 0
selected - selezionate 0
volume - volumi 1.871
Totale 116.974


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2019/2020248 0 0 0 0 0 0 0 0 0 0 73 175
2020/20211.547 91 310 45 134 226 192 18 147 127 23 137 97
2021/20221.254 72 282 25 57 42 29 12 91 60 31 140 413
2022/20232.732 253 166 332 431 290 572 33 183 320 30 70 52
2023/20241.351 71 129 111 118 162 187 47 92 19 83 190 142
2024/20252.848 285 251 171 554 177 137 216 178 566 280 33 0
Totale 16.246